Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging

J Nucl Med. 2009 Oct;50(10):1594-7. doi: 10.2967/jnumed.109.064121. Epub 2009 Sep 16.

Abstract

Many studies demonstrate a high accuracy for PET in staging lymphoma, but few assess observer variation. This study quantified agreement for staging lymphoma with PET/CT.

Methods: The PET/CT images of 100 patients with lymphoma who had been referred for staging were reviewed by 3 experienced observers, with 2 observers reviewing each series a second time. Ann Arbor stage and individual nodal and extranodal regions were assessed. Weighted kappa (kappa(w)) and intraclass correlation coefficient were used to compare ratings.

Results: Intra- and interobserver agreement was high for Ann Arbor stage (kappa(w) = 0.79-0.91), number of nodal regions involved (intraclass correlation coefficient, 0.83-0.93), and presence of extranodal disease (kappa = 0.74-0.86). High agreement was also observed for all nodal regions (kappa(w) > 0.60) except hilar (kappa(w) = 0.56-0.82) and infraclavicular (kappa(w) = 0.14-0.55). Lower agreement was observed for bowel involvement (kappa(w) = 0.37-0.71).

Conclusion: Experienced observers had a high level of agreement using PET/CT for lymphoma staging, supporting its use as a robust noninvasive staging tool. Further research is needed to evaluate observer variability for restaging during and after chemotherapy.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Fluorodeoxyglucose F18*
  • Humans
  • Image Interpretation, Computer-Assisted / methods*
  • Lymphoma / diagnosis*
  • Lymphoma / diagnostic imaging
  • Lymphoma / pathology*
  • Middle Aged
  • Neoplasm Staging
  • Observer Variation
  • Positron-Emission Tomography*
  • Tomography, X-Ray Computed
  • Young Adult

Substances

  • Fluorodeoxyglucose F18